Abstract
Human β-defensin-2 (hBD2) is A small cationic peptide with A broad range of antimicrobial activity. An E. coli cell-free system was employed to express the hBD2 fusion protein by using the hBD2 gene with 14 rare codons. The results showed that the expression level of trxA-hBD2 fusion protein was 0.35 mg/ml, which is the same as that obtained with A synthetic codon-optimized gene. By using another fusion partner (GFP), similar high-level expression was also achieved in this cell-free system. This meant that human beta-defensin-2 gene could be directly used to express hBD2 fusion protein efficiently in an E. coli cell-free system without the optimization of codons. The expression level of hBD2 fused with thioredoxin could be further improved up to 2.0 mg/ml by adopting A continuous exchange cell-free system. A simple one-stage affinity purification procedure was also developed to recover this fusion protein efficiently.
Keywords: Human beta-defensin-2, cell-free system, codon usage, fusion protein, antimicrobial peptide, protein purification
Protein & Peptide Letters
Title: High-Level Expression of Human β-Defensin-2 Gene with Rare Codons in E. coli Cell-Free System
Volume: 13 Issue: 2
Author(s): Haiqin Chen, Zhinan Xu, Naizheng Xu and Peilin Cen
Affiliation:
Keywords: Human beta-defensin-2, cell-free system, codon usage, fusion protein, antimicrobial peptide, protein purification
Abstract: Human β-defensin-2 (hBD2) is A small cationic peptide with A broad range of antimicrobial activity. An E. coli cell-free system was employed to express the hBD2 fusion protein by using the hBD2 gene with 14 rare codons. The results showed that the expression level of trxA-hBD2 fusion protein was 0.35 mg/ml, which is the same as that obtained with A synthetic codon-optimized gene. By using another fusion partner (GFP), similar high-level expression was also achieved in this cell-free system. This meant that human beta-defensin-2 gene could be directly used to express hBD2 fusion protein efficiently in an E. coli cell-free system without the optimization of codons. The expression level of hBD2 fused with thioredoxin could be further improved up to 2.0 mg/ml by adopting A continuous exchange cell-free system. A simple one-stage affinity purification procedure was also developed to recover this fusion protein efficiently.
Export Options
About this article
Cite this article as:
Chen Haiqin, Xu Zhinan, Xu Naizheng and Cen Peilin, High-Level Expression of Human β-Defensin-2 Gene with Rare Codons in E. coli Cell-Free System, Protein & Peptide Letters 2006; 13 (2) . https://dx.doi.org/10.2174/092986606775101724
DOI https://dx.doi.org/10.2174/092986606775101724 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Urokinase-a Very Popular Cardiovascular Agent
Recent Patents on Cardiovascular Drug Discovery Histopathology Image Analysis and Classification Using ARMA Models: Application to Brain Cancer Detection
Current Medical Imaging Investigation of the pH Dependent Cytotoxicity of Paclitaxel Conjugated Gold Nanoparticles
Pharmaceutical Nanotechnology The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity
Current Drug Delivery Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis
Current HIV Research Immunomodulatory Effects of Soybeans and Processed Soy Food Compounds
Recent Patents on Food, Nutrition & Agriculture Ketamine: New Indications for an Old Drug
Current Drug Targets Formamide Derivatives of Resveratrol: Synthesis, Characterization and Cytotoxicity
Letters in Drug Design & Discovery Medicinal Electrochemistry: Integration of Electrochemistry, Medicinal Chemistry and Computational Chemistry
Current Medicinal Chemistry Xenicane Natural Products: Biological Activity and Total Synthesis
Current Pharmaceutical Design Recent Development in Applications of Important Biopolymer Chitosan in Biomedicine, Pharmaceuticals and Personal Care Products
Current Tissue Engineering (Discontinued) Antiviral Properties of Food Plants could help to Reduce Contagion and Severity in SARS-CoV-2 Infection
Current Traditional Medicine Tolfenamic Acid Prevents Amyloid β-induced Olfactory Bulb Dysfunction In Vivo
Current Alzheimer Research Focus on the Multimodal Role of Biomarkers in Breast Cancer
Current Pharmaceutical Design Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs
Current Drug Metabolism Pleural Fluid Analysis for Evaluating Pleural Effusions
Current Respiratory Medicine Reviews Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs
Current Medicinal Chemistry Major CYP450 Polymorphism among Saudi Patients
Drug Metabolism Letters Cytoprotective Effects of 5 Benzophenones and a Xanthone from Hypericum annulatum in Models of Epirubicin-Induced Cytotoxicity: SARAnalysis and Mechanistic Investigations
Medicinal Chemistry Morphological Characterization of Lipid Structured Nanoparticles by Atomic Force Microscopy while Minimizing the Formation of Failed Artefacts
Current Nanomaterials